The substance P/neurokinin-1 receptor system in lung cancer: Focus on the antitumor action of neurokinin-1 receptor antagonists

Peptides

Volumn 38, Issue 2, 2012, Pages 318-325

  Muñoz, Miguel ^a   González Ortega, Ana ^a   Rosso, Marisa ^a   Robles Frias, María José ^a   Carranza, Andres ^a   Salinas Martín, Manuel Vicente ^a   Coveñas, Rafael ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Apoptosis; Aprepitant; L 732,138; L 733,060; Non small cell lung cancer; Small cell lung cancer

Indexed keywords

APREPITANT; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; SMALL INTERFERING RNA; SUBSTANCE P;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER INHIBITION; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 84868700225     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.09.024     Document Type: Article

References (33)

1. T. Akazawa, S.G. Kwatra, L.E. Goldsmith, M.D. Richardson, E.A. Cox, and J.H. Sampom A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas J Neurochem 109 2009 1079 1086
2. M.R. Choi, C. Jiles, and N.L. Seibel Aprepitant use in children, adolescents, and young adults for the control of chemotherapy-induced nausea and vomiting (CINV) J Pediatr Hematol Oncol 32 2010 e268 e271
3. J.R. Conejo, J. Kleeff, A. Koliopanos, K. Matsuda, Z.W. Zhu, and H. Goecke Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers Int J Cancer 88 2000 12 20
4. K.A. DeFea, Z.D. Vaughn, E.M. O'Bryan, D. Nishijima, O. Dery, and N.W. Bunnett The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestin-dependent scaffolding complex Proc Natl Acad Sci USA 97 2000 11086 11091
5. F. Esteban, M. Muñoz, M.A. González-Moles, and M. Rosso A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage Cancer Metast Rev 25 2006 137 145
6. T.P. Fan, D.E. Hu, S. Guard, G.A. Gresham, and K.J. Watling Stimulation of angiogenesis by substance P an interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists Br J Pharmacol 110 1993 43 49
7. H. Friess, Z. Zhu, V. Liard, X. Shi, S.V. Shrikhande, and L. Wang Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer Lab Invest 83 2003 731 742
8. M.A. González-Moles, A. Mosqueda-Taylor, F. Esteban, J.A. Gil-Montoya, M.A. Díaz-Franco, and M. Delgado Cell proliferation associated with actions of the substance P/NK1 receptor complex in keratocystic odontogenic tumours Oral Oncol 44 2008 1127 1133
9. I.M. Hennig, J.A. Laissue, U. Horisberger, and J.C. Reubi Substance-P receptors in human primary neoplasms: tumoral and vascular localization Int J Cancer 61 1995 786 792
10. P.H. Hodkinson, A. MacKinnon, and T. Sethi Targeting growth factors in lung cancer Chest 133 2008 1209 1216
11. K. Lang, T.L. Drell, A. Lindecke, B. Niggemann, C. Kaltschmidt, and K.S. Zaenker Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs Int J Cancer 112 2004 231 238
12. S. Langdon, T. Sethi, A. Ritchie, M. Muir, J. Smyth, and E. Rozengurt Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo Cancer Res 52 1992 4554 4557
13. W. Luo, T.R. Sharif, and M. Sharif Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway Cancer Res 56 1995 4983 4991
14. J. Meshki, S.D. Douglas, J.P. Lai, L. Schwartz, L.E. Kilpatrick, and F. Tuluc Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho/Rho-associated coiled-coil kinase-dependent mechanism J Biol Chem 284 2009 9280 9289
15. kip1 determine Aplidin sensitivity Mol Cancer Ther 6 2007 1310 1316
16. M. Muñoz, A. González-Ortega, and R. Coveñas The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines Invest New Drugs 30 2012 529 540
17. M. Muñoz, A. Pérez, M. Rosso, C. Zamarriego, and R. Rosso Antitumoural action of NK1 receptor antagonist L-733,060 on human melanoma cell lines Melanoma Res 14 2004 183 188
18. M. Muñoz, M. Rosso, F.J. Aguilar, M.A. González-Moles, M. Redondo, and F. Esteban NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2 Invest New Drugs 26 2008 111 118
19. M. Muñoz, M. Rosso, and R. Coveñas A new frontier in the treatment of cancer: NK-1 receptor antagonists Curr Med Chem 17 2010 504 516
20. M. Muñoz, M. Rosso, and R. Coveñas The NK-1 receptor: a new target in cancer therapy Curr Drug Targets 12 2011 909 921
21. M. Muñoz, M. Rosso, R. Coveñas, I. Montero, M.A. González-Moles, and M.J. Robles Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138 Invest Ophthalmol Vis Sci 48 2007 2775 2781
22. M. Muñoz, M. Rosso, A. Pérez, R. Coveñas, C. Zamarriego, and J.I. Piruat The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines Neuropeptides 39 2005 427 432
23. M. Muñoz, M. Rosso, M.J. Robles-Frias, M.V. Salinas-Martín, and R. Coveñas The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines Lab Invest 90 2010 1259 1269
24. C. Palma Tachykinins and their receptors in human malignancies Curr Drug Targets 7 2006 1043 1052
25. C. Palma, F. Nardelli, S. Manzini, and C.A. Maggi Substance P activates responses correlated with tumor growth in human glioma cells line bearing tachykinin NK1 receptors Br J Cancer 79 1999 236 243
26. 11] Substance P induces apoptosis in lung cancer cell lines in vitro Biochem Biophys Res Commun 199 1994 1313 1319
27. H.C. Seegers, V.C. Hood, B.L. Kidd, S.C. Cruwys, and D.A. Walsch Enhancement of angiogenesis by endogenous substance P release and neurokinin-1 receptors during neurogenic inflammation J Pharmacol Exp Ther 306 2003 8 12
28. T. Sethi, S. Langdon, J. Smyth, and E. Rozengurt Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo Cancer Res 52 1992 2737 2742
29. S.V. Shrikhande, H. Friess, F.F. di Mola, A. Tempia-Caliera, J.R. Conejo García, and Z. Zhu NK-1 receptor gene expression is related to pain in chronic pancreatitis Pain 91 2001 209 217
30. D. Singh, D.D. Joshi, M. Hameed, J. Qian, P. Gascón, and P.B. Maloof Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis Proc Natl Acad Sci USA 97 2000 1388 1393
31. D.A. Walsh, D.E. Hu, P.I. Mapp, J.M. Polak, D.R. Blake, and T.P. Fan Innervation and neurokinin receptors during angiogenesis in the rat sponge granuloma J Histochem Cytochem 28 1996 759 769
32. 11] substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro Proc Natl Acad Sci USA 85 1988 1859 1863
33. M. Ziche, L. Morbidelli, M. Pacini, P. Gepetti, G. Alessandri, and Maggi C.A. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells Microvasc Res 40 1990 264 278